Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityNo recent work listed

Liting Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8277-5576; OpenAlex author ID A5101828035. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

  1. METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fcell.2022.759020↗
  2. SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jgm.3364↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shineng Zhang · 2 shared papers, 2021–2022 · strength 0.29
  2. Juanfei Peng · 2 shared papers, 2021–2022 · strength 0.29
  3. Fengting Huang · 2 shared papers, 2021–2022 · strength 0.29
  4. Yanyan Zhuang · 2 shared papers, 2021–2022 · strength 0.29
  5. Sihua Lan · 1 shared paper, 2022 · strength 0.16
  6. Wen‐Ying Chen · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.